Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
about
The role of chromatin in adenoviral vector functionGutless adenovirus: last-generation adenovirus for gene therapyProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector.Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vectorRegulatable atrial natriuretic peptide gene therapy for hypertension.Inhibition and regression of atherosclerotic lesions.Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesRecent advances in liver-directed gene therapy for dyslipidemia.Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusHelper-dependent adenoviral vectors for liver-directed gene therapy.Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.Development and use of gene transfer for treatment of cardiovascular disease.Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficienSustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.Gene therapy of liver diseases.Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications.Gene therapy for lipoprotein disorders.Helper-dependent adenoviral vectors in experimental gene therapy.Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial HypercholesterolemiaSleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial HypercholesterolemiaInterleukin-7 induces recruitment of monocytes/macrophages to endothelium.Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaAtherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediatorsHepatocyte growth factor enhances engraftment and function of nonhuman primate islets.Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.Cardiac gene therapy: are we there yet?Familial hypercholesterolaemia presenting with coronary artery disease in a young patient.A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vectorRobust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors.Helper-dependent adenoviral vectors.Engineering adeno-associated virus 2 vectors for targeted gene delivery to atherosclerotic lesions.Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.Neo-islet formation in liver of diabetic mice by helper-dependent adenoviral vector-mediated gene transfer.Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression.
P2860
Q27004695-04B95980-055B-4D72-AE7C-1B1175BBCF4FQ28277560-77A24B98-A3FA-4D8F-9D3F-628B69AC9F68Q30226988-A8B11991-C186-4E38-A5F1-B7012D43C64EQ33364520-8F9DF934-5556-4CF8-96BA-F23BCF298A24Q33691863-1B831004-FF41-4D19-BB34-DE4F8F65D285Q33926011-8025CAE6-B063-4E7C-ACCC-03A0E6375FE7Q33949311-0E36A636-D8B4-4DEC-B30A-5929401FFEB0Q34048214-3EDD15D4-ACAA-45C0-BAAA-248D4A76CC84Q34335187-40BFDDD5-6C80-455B-9C70-4F447441B814Q34355206-25F0C1ED-101E-4E9D-AA49-95B5B2704341Q34467839-6CB1FEBE-99A3-4B57-9354-20C5B6D548A8Q34586826-19842B5B-299B-407B-9442-B360220C9EC2Q34975214-262FB3FA-3119-49D5-9E64-B7D6CF3040F5Q34982825-2B05C2CB-868E-427B-B759-C033396F596BQ34999908-12225C77-2586-4959-B1A0-2A64DE952CD6Q35087832-88B791AE-7F50-4534-AC67-23DE51381F45Q35088381-9A869ADA-414D-4F22-9BC9-151705F1FD03Q35607028-CAA5A741-625E-49B6-9871-48840EAAA680Q35842662-DC2450C7-8382-4881-A812-F84832E61582Q36050486-E2965602-FB16-4F6D-BC2E-A5742C52C2F2Q36210853-914BF2E0-7F5A-4025-A2CE-38EDBACA4487Q36219334-8CCF6F32-061B-4A46-B09E-52E510007C45Q36344509-C3A90E3E-D9FE-4D80-B4C7-C74E8BDEDA3CQ36675313-928A1749-8DAD-4A0C-94A0-94D3B95AD8EDQ36687078-C4B8CC05-943D-4558-A21A-2EDA3FE3F3A7Q36811505-9717E68E-3DC0-4EEE-94F6-1ECE17FAB287Q36879456-431D8EA0-1031-465F-BE5A-49A8615C63AEQ36906375-08493519-2C61-48A1-8541-19454736EE93Q37215836-6A7BA087-D25C-4780-84E3-5A1608C7C4B3Q37241434-8C2D21D1-C123-42C9-9035-8C75FCA95076Q37666136-8CEFC6F0-C136-4B09-94FE-3C835160FF70Q38820937-D5A54D08-6EEE-4F6B-8784-2B19828FED59Q39654218-79CF4181-4FFD-4380-8929-5F9F08ED73D9Q39733540-7348AC3D-E4AC-4AEA-9941-9A67A0C74E62Q39933737-F97796EF-1CA4-473E-BA5D-986C416E4E9AQ39989693-A1A7CA6D-C1CE-4C10-BF26-B82FF7CEE702Q40051540-C7C1D1CA-077E-4303-86E2-9F4230A7B039Q40582642-5237D378-7D6E-406B-9778-A4E0AB674DDBQ41460762-6779C2BD-4B41-46C1-8067-EA65037475B0Q42002320-C339CFF3-4160-4B3A-89D0-A781528E2E7A
P2860
Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-term stable correction of ...... -density lipoprotein receptor.
@ast
Long-term stable correction of ...... -density lipoprotein receptor.
@en
type
label
Long-term stable correction of ...... -density lipoprotein receptor.
@ast
Long-term stable correction of ...... -density lipoprotein receptor.
@en
prefLabel
Long-term stable correction of ...... -density lipoprotein receptor.
@ast
Long-term stable correction of ...... -density lipoprotein receptor.
@en
P2093
P1433
P1476
Long-term stable correction of ...... -density lipoprotein receptor.
@en
P2093
Arden-Riley C
Finegold M
Merched-Sauvage M
P304
P356
10.1161/01.CIR.103.9.1274
P407
P577
2001-03-01T00:00:00Z